Our study was only powered to find an odds ratio of greater than 1.075, so if enhanced IL-6 trans-signaling does contribute to the pathogenesis of COPD, it is likely that this relationship is weaker than that observed for asthma in previous studies and may therefore be of limited clinical relevance. The gene discussed is IL6; the disease is asthma.